PIMFA Response Papers

PIMFA responds on behalf of our membership to numerous key issues within our industry. We do this via vital feedback and discussion with member firms via our committees, working parties and industry forums.

From this member feedback PIMFA create responses to consultation documents and discussion papers issued by bodies such as the UK’s regulator, the Financial Conduct Authority (FCA), Government departments and many European and International bodies.

  • Response Recipients

205 papers found. Page 6 of 11.

Month Published: December 2019

  • 2019 Consultation Responses
  • ESMA

Month Published: November 2019

  • 2019 Consultation Responses
  • ESMA

Month Published: October 2019

  • 2019 Consultation Responses

Month Published: October 2019

  • 2019 Consultation Responses

Month Published: October 2019

  • 2019 Consultation Responses

Month Published: September 2019

  • 2019 Consultation Responses

Month Published: September 2019

  • 2019 Consultation Responses
  • FCA

Month Published: August 2019

  • 2019 Consultation Responses

Month Published: August 2019

  • 2019 Consultation Responses
  • HM Treasury

Month Published: August 2019

  • 2019 Consultation Responses
  • Department for Business, Energy & Industrial Strategy

Month Published: July 2019

  • 2019 Consultation Responses
  • DCMS

Month Published: June 2019

  • 2019 Consultation Responses
  • FCA

Month Published: June 2019

  • 2019 Consultation Responses
  • FCA

Month Published: June 2019

  • 2019 Consultation Responses
  • HM Treasury

Month Published: April 2019

  • 2019 Discussion Paper Responses

Month Published: March 2019

  • 2019 Consultation Responses
  • FCA
Page 6 of 11

 

The scope of regulation is increasing all the time and one of PIMFA’s key objectives is to ensure this regulation is proportionate and fair, bringing real benefits to the investment management and financial advice community and their clients.

Past consultation responses from WMA and APFA can be accessed via their respective archives.